Haemonetics director Martin D. Madaus files initial beneficial ownership statement
HAE•Initial Section 16 filing for director
Haemonetics filed an initial Section 16 Form 3 for director Martin D. Madaus, triggered by an event dated July 24, 2026.
HAE•
